• 1. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 4. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

• Solvents and Organic Chemicals Organic Compounds Benzenoids Tetralins Tetralins
• Solvents and Organic Chemicals Organic Compounds Benzenoids Tetralins

Comprehensive Overview of 2-Naphthalenemethanamine, 1,2,3,4-tetrahydro-α-methyl-, (αS)- (CAS No. 1372913-69-3)

The compound 2-Naphthalenemethanamine, 1,2,3,4-tetrahydro-α-methyl-, (αS)- (CAS No. 1372913-69-3) is a chiral amine derivative with a naphthalene backbone, widely recognized for its potential applications in pharmaceutical and organic synthesis. Its unique stereochemistry, denoted by the (αS) configuration, makes it a valuable intermediate in asymmetric synthesis. Researchers and industries are increasingly interested in this compound due to its role in developing enantioselective catalysts and bioactive molecules, aligning with the growing demand for precision in drug design and green chemistry.

In recent years, the scientific community has focused on sustainable synthesis methods and chiral building blocks, both of which are highly relevant to 2-Naphthalenemethanamine, 1,2,3,4-tetrahydro-α-methyl-, (αS)-. Searches for terms like "chiral amine applications" and "naphthalene derivatives in drug discovery" have surged, reflecting its importance in modern research. This compound’s structural features, including the tetrahydro-naphthalene core and methyl-substituted amine, contribute to its versatility in creating high-value intermediates for APIs (Active Pharmaceutical Ingredients).

From a synthetic perspective, CAS No. 1372913-69-3 is often explored for its potential in catalysis and material science. Its stereocenter at the α-position enables selective transformations, a key requirement in industries prioritizing atom economy and waste reduction. Questions like "How to optimize chiral amine synthesis?" or "Role of naphthalene derivatives in OLEDs" frequently appear in academic and industrial forums, underscoring its cross-disciplinary relevance.

Furthermore, the compound’s physicochemical properties, such as solubility and stability, are critical for formulation scientists. Trends in computational chemistry and AI-driven molecular design have also highlighted the need for reliable data on compounds like 2-Naphthalenemethanamine, 1,2,3,4-tetrahydro-α-methyl-, (αS)-. This aligns with the rise of digital lab notebooks and predictive modeling tools, which rely on accurate compound profiles for virtual screening.

In conclusion, 2-Naphthalenemethanamine, 1,2,3,4-tetrahydro-α-methyl-, (αS)- represents a compelling case study in the intersection of chiral chemistry and applied research. Its CAS No. 1372913-69-3 serves as a gateway to innovations in pharmaceuticals, materials, and beyond, addressing both current challenges and future opportunities in science.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)